2014 is a year of vigorous development of the bio-pharmaceutical industry. The overall time is rising, the heat is constant but there is no boiling point. Most companies are facing transformation, especially foreign companies, and the layout of domestic listed companies brings different industries. Aspects:
1. National investment transformation
As the most important competitive qualification of the Chinese government, 863,973 will be cancelled, and the country will naturally be treated as a rising dimension. From the news obtained by relevant parties, the government will set up a corporate management fund to open up funds for scientific research and innovation. Companies that have not yet changed their decision-making from this level of information will undoubtedly encounter huge winters.
2.The Chinese layout after ThermoFisher acquired Life
Historically, after the acquisition of ABI by Invitrogen in June 2008, the Chinese market has been integrated for three years. This has caused confusion for a large number of users, and the channels that were still in the limelight provided a lot of strength. The current M&A integration seems to be much faster. The reason is that we are more willing to understand that the opening of the information channel provides a good space for the integration of capital layout.
Cervical Ripening Balloon,cervical dilation Catheter,Silicone Cervical Ripening Balloon,Silicone Cerivcal Dilation Catheter
Anesthesia Medical Co., Ltd. , https://www.medicaldiverse.com